dosage schedule for antipyretic combination formulations: experts’ reply i

1
CORRESPONDENCE Dosage Schedule for Antipyretic Combination Formulations: ExpertsReply I Sunil Gomber & Manish Saxena Received: 15 April 2013 / Accepted: 16 April 2013 # Dr. K C Chaudhuri Foundation 2013 To the Editor: Paracetamol (acetaminophen) as an antipyretic is available as a single drug as well as in combination with other NSAIDs like ibuprofen, mefenemic acid etc. We are trying to find out rationale of such combination, the dosage and frequency of such combination if they are to be used and whether of such combination leads to any interactions. ACETAMINOPHEN (Drug A) with IBUPROFEN (Drug B) Both of above drugs have same mechanism of action by decreasing prostaglandin synthesis in CNS. There are no significant interactions between the two drugs [1]. There are pharmacokinetic differences between the two [2]: Drug A Drug B Onset of action 1060 min <1 y: 69±22 min; > 6 y: 109±64 min Duration of action 46h 68h Thus therapeutic effect of (A + B) is equal to A or B as there are no interactions between the two drugs and both have same mechanism of action. The only advantage this combination offers against the two drugs individually is early onset of action by virtue of drug A and prolonged action by virtue of drug B. If the combination is anyways chosen the dosage of such combination can be calculated on basis of any one constituent as the preparation available in market have both drugs in same strength as their single drug preparation. Frequency can be judged on basis of drug with longer duration of action. ACETAMINOPHEN (Drug A) with MEFENEMIC ACID (Drug B) Mefenemic acid is also an NSAID which is primarily used as short term relief of mild to moderate pain including primary dysmenorrhoea [1]. It is not a preferred antipyretic [3, 4], also its use is not recommended in children and pregnant women [1]. Thus its combination with acetamin- ophen as an antipyretic is not justified. The two drugs namely ibuprofen and mefenemic acid do have significant side effects [1] and as such Acetaminophen is preferred antipyretic [4]. The combination of these drugs does not offer much but increases the chances of adverse effects, thus acetaminophen along with tepid sponging seems to be more prudent way for antipyresis. References 1. Grosser T, Smyth E, Fitzgerald GA. Anti-inflammatory anti- pyretic and analgesic agents; Pharmacotherapy of gout. In: Brunton LL, Chabner BA, Knollman BC, eds. Goodman and Gillman Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw Hill; 2011. pp. 9824; 9879. 2. Taketomo CK, Hodding JH, Krauss DM. Lexi-comps Pediatric Dosage Handbook International. 1997;13e: pp. 3942; 7237. 3. Balasubramanian S, Sumanth A. Mefenamic acid-role as antipyretic. Indian Pediatr. 2010;47:453. 4. Chandra J, Bhatnagar SK. Antipyretics in children. Indian J Pediatr. 2002;69:6974. S. Gomber (*) : M. Saxena Department of Pediatrics, UCMS & GTB Hospital Delhi 110095, India e-mail: [email protected] Indian J Pediatr DOI 10.1007/s12098-013-1053-4

Upload: manish-saxena

Post on 11-Dec-2016

215 views

Category:

Documents


3 download

TRANSCRIPT

CORRESPONDENCE

Dosage Schedule for Antipyretic Combination Formulations:Experts’ Reply I

Sunil Gomber & Manish Saxena

Received: 15 April 2013 /Accepted: 16 April 2013# Dr. K C Chaudhuri Foundation 2013

To the Editor: Paracetamol (acetaminophen) as an antipyreticis available as a single drug as well as in combination withother NSAIDs like ibuprofen, mefenemic acid etc. We aretrying to find out rationale of such combination, the dosageand frequency of such combination if they are to be used andwhether of such combination leads to any interactions.

ACETAMINOPHEN (Drug A) with IBUPROFEN(Drug B)

Both of above drugs have same mechanism of action bydecreasing prostaglandin synthesis in CNS. There are nosignificant interactions between the two drugs [1]. There arepharmacokinetic differences between the two [2]:

Drug A Drug B

Onset of action 10–60 min <1 y: 69±22 min; >6 y: 109±64 min

Duration of action 4–6 h 6–8 h

Thus therapeutic effect of (A + B) is equal to A or B asthere are no interactions between the two drugs and bothhave same mechanism of action. The only advantage thiscombination offers against the two drugs individually isearly onset of action by virtue of drug A and prolongedaction by virtue of drug B. If the combination is anywayschosen the dosage of such combination can be calculated onbasis of any one constituent as the preparation available in

market have both drugs in same strength as their single drugpreparation. Frequency can be judged on basis of drug withlonger duration of action.

ACETAMINOPHEN (Drug A) with MEFENEMICACID (Drug B)

Mefenemic acid is also an NSAID which is primarilyused as short term relief of mild to moderate painincluding primary dysmenorrhoea [1]. It is not a preferredantipyretic [3, 4], also its use is not recommended in childrenand pregnant women [1]. Thus its combination with acetamin-ophen as an antipyretic is not justified.

The two drugs namely ibuprofen and mefenemic acid dohave significant side effects [1] and as such Acetaminophenis preferred antipyretic [4]. The combination of these drugsdoes not offer much but increases the chances of adverseeffects, thus acetaminophen along with tepid spongingseems to be more prudent way for antipyresis.

References

1. Grosser T, Smyth E, Fitzgerald GA. Anti-inflammatory anti-pyretic and analgesic agents; Pharmacotherapy of gout. In:Brunton LL, Chabner BA, Knollman BC, eds. Goodman andGillman Pharmacological Basis of Therapeutics. 12th ed. NewYork: McGraw Hill; 2011. pp. 982–4; 987–9.

2. Taketomo CK, Hodding JH, Krauss DM. Lexi-comp’s PediatricDosage Handbook International. 1997;13e: pp. 39–42; 723–7.

3. Balasubramanian S, Sumanth A. Mefenamic acid-role as antipyretic.Indian Pediatr. 2010;47:453.

4. Chandra J, Bhatnagar SK. Antipyretics in children. Indian J Pediatr.2002;69:69–74.

S. Gomber (*) :M. SaxenaDepartment of Pediatrics, UCMS & GTB HospitalDelhi 110095, Indiae-mail: [email protected]

Indian J PediatrDOI 10.1007/s12098-013-1053-4